Home / Gemcitabine / Canada
CA ATC L01BC05 · updated 2 Nov 2026
Gemcitabine shortage in Canada
Is there a Gemcitabine shortage in Canada?
Yes. As of 2 Nov 2026, 3 Gemcitabine products are reported short in Canada, the first since 2 Nov 2026. The company estimate for the return is 31 Dec 2028. Main reason: manufacturing problem.
Also short in Germany, France, Italy, Spain, Belgium, Switzerland, Czechia, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | GEMCITABINE INJECTION (1x52.6ml Vial) | PFIZER CANADA ULC | 2 Nov 2026 | 31 Dec 2028 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | GEMCITABINE INJECTION (1x5.3ml Vial) anticipated | PFIZER CANADA ULC | 17 May 2027 | 31 Dec 2028 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | GEMCITABINE INJECTION (1x26.3ml Vial) anticipated | PFIZER CANADA ULC | 27 May 2027 | 31 Dec 2028 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.